The above was mentioned in last weeks update which may not have been picked up by as many when skimming over the document. Hopefully the future will see Oncosil making a difference to a broader group of cancer sufferers.
- "OncoSil has been approached to conduct a percutaneous trial which it intends to support. A percutaneous approach would allow OncoSil to be used more widely in the body with other indications. This is aimed at expanding our user base to include Interventional Radiologists who could administer the OncoSilTM device.OncoSil has been approached to conduct a percutaneous trial which it intends to support."
Ann: Bupa UK Approves Reimbursement for OncoSil in the UK, page-9
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(11.1%) |
Mkt cap ! $13.32M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $23.68K | 4.971M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 23118264 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 5200224 | 7 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| OSL (ASX) Chart |